These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 35165282)
1. EBV miRNAs BART11 and BART17-3p promote immune escape through the enhancer-mediated transcription of PD-L1. Wang J; Ge J; Wang Y; Xiong F; Guo J; Jiang X; Zhang L; Deng X; Gong Z; Zhang S; Yan Q; He Y; Li X; Shi L; Guo C; Wang F; Li Z; Zhou M; Xiang B; Li Y; Xiong W; Zeng Z Nat Commun; 2022 Feb; 13(1):866. PubMed ID: 35165282 [TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1. Song Y; Li X; Zeng Z; Li Q; Gong Z; Liao Q; Li X; Chen P; Xiang B; Zhang W; Xiong F; Zhou Y; Zhou M; Ma J; Li Y; Chen X; Li G; Xiong W Oncotarget; 2016 Jun; 7(24):36783-36799. PubMed ID: 27167345 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-encoded miR-BART11 promotes tumor-associated macrophage-induced epithelial-mesenchymal transition via targeting FOXP1 in gastric cancer. Song Y; Li Q; Liao S; Zhong K; Jin Y; Zeng T Virology; 2020 Sep; 548():6-16. PubMed ID: 32530809 [TBL] [Abstract][Full Text] [Related]
4. EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma. Lung RW; Hau PM; Yu KH; Yip KY; Tong JH; Chak WP; Chan AW; Lam KH; Lo AK; Tin EK; Chau SL; Pang JC; Kwan JS; Busson P; Young LS; Yap LF; Tsao SW; To KF; Lo KW J Pathol; 2018 Apr; 244(4):394-407. PubMed ID: 29230817 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-encoded miR-BART5-5p upregulates PD-L1 through PIAS3/pSTAT3 modulation, worsening clinical outcomes of PD-L1-positive gastric carcinomas. Yoon CJ; Chang MS; Kim DH; Kim W; Koo BK; Yun SC; Kim SH; Kim YS; Woo JH Gastric Cancer; 2020 Sep; 23(5):780-795. PubMed ID: 32206940 [TBL] [Abstract][Full Text] [Related]
6. EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC. Yan Q; Zeng Z; Gong Z; Zhang W; Li X; He B; Song Y; Li Q; Zeng Y; Liao Q; Chen P; Shi L; Fan S; Xiang B; Ma J; Zhou M; Li X; Yang J; Xiong W; Li G Oncotarget; 2015 Dec; 6(39):41766-82. PubMed ID: 26497204 [TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell proliferation through the LOC553103-STMN1 axis. Wang D; Zeng Z; Zhang S; Xiong F; He B; Wu Y; Li W; Tang L; Wei F; Xiang B; Li Z; Zhou Y; Zhou M; Li X; Li Y; Li G; Xiong W; Guo C FASEB J; 2020 Jun; 34(6):8012-8027. PubMed ID: 32306460 [TBL] [Abstract][Full Text] [Related]
8. Detection of Epstein-Barr virus (EBV)-encoded microRNAs in plasma of patients with nasopharyngeal carcinoma. Gao W; Wong TS; Lv KX; Zhang MJ; Tsang RK; Chan JY Head Neck; 2019 Mar; 41(3):780-792. PubMed ID: 30548946 [TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression. Zheng X; Wang J; Wei L; Peng Q; Gao Y; Fu Y; Lu Y; Qin Z; Zhang X; Lu J; Ou C; Li Z; Zhang X; Liu P; Xiong W; Li G; Yan Q; Ma J J Virol; 2018 Dec; 92(23):. PubMed ID: 30209170 [TBL] [Abstract][Full Text] [Related]
10. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways. Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559 [TBL] [Abstract][Full Text] [Related]
11. ARID1A deficiency in EBV-positive gastric cancer is partially regulated by EBV-encoded miRNAs, but not by DNA promotor hypermethylation. Kase K; Saito M; Nakajima S; Takayanagi D; Saito K; Yamada L; Ashizawa M; Nakano H; Hanayama H; Onozawa H; Okayama H; Endo H; Fujita S; Sakamoto W; Saze Z; Momma T; Mimura K; Ohki S; Shiraishi K; Kohno T; Kono K Carcinogenesis; 2021 Feb; 42(1):21-30. PubMed ID: 33196828 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr Virus-Encoded Circular RNA CircBART2.2 Promotes Immune Escape of Nasopharyngeal Carcinoma by Regulating PD-L1. Ge J; Wang J; Xiong F; Jiang X; Zhu K; Wang Y; Mo Y; Gong Z; Zhang S; He Y; Li X; Shi L; Guo C; Wang F; Zhou M; Xiang B; Li Y; Li G; Xiong W; Zeng Z Cancer Res; 2021 Oct; 81(19):5074-5088. PubMed ID: 34321242 [TBL] [Abstract][Full Text] [Related]
13. EBV-miR-BART12 accelerates migration and invasion in EBV-associated cancer cells by targeting tubulin polymerization-promoting protein 1. Wu Y; Wang D; Wei F; Xiong F; Zhang S; Gong Z; Shi L; Li X; Xiang B; Ma J; Deng H; He Y; Liao Q; Zhang W; Li X; Li Y; Guo C; Zeng Z; Li G; Xiong W FASEB J; 2020 Dec; 34(12):16205-16223. PubMed ID: 33094864 [TBL] [Abstract][Full Text] [Related]
14. The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1. Sugita Y; Furuta T; Ohshima K; Komaki S; Miyoshi J; Morioka M; Abe H; Nozawa T; Fujii Y; Takahashi H; Kakita A Neuropathology; 2018 Apr; 38(2):125-134. PubMed ID: 29067721 [TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr Virus Epithelial Cancers-A Comprehensive Understanding to Drive Novel Therapies. Han S; Tay JK; Loh CJL; Chu AJM; Yeong JPS; Lim CM; Toh HC Front Immunol; 2021; 12():734293. PubMed ID: 34956172 [TBL] [Abstract][Full Text] [Related]
16. Expression of Immune Checkpoint Regulators, Cytotoxic T-Lymphocyte Antigen-4, and Programmed Death-Ligand 1 in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma. Ahmed MM; Gebriel MG; Morad EA; Saber IM; Elwan A; Salah M; Fakhr AE; Shalaby AM; Alabiad MA Appl Immunohistochem Mol Morphol; 2021 Jul; 29(6):401-408. PubMed ID: 33480605 [TBL] [Abstract][Full Text] [Related]
17. Eukaryotic initiating factor eIF4E is targeted by EBV-encoded miR-BART11-3p and regulates cell cycle and apoptosis in EBV-associated gastric carcinoma. Wang H; Liu J; Zhang Y; Sun L; Zhao M; Luo B Virus Genes; 2021 Aug; 57(4):358-368. PubMed ID: 34146250 [TBL] [Abstract][Full Text] [Related]
18. [Correlation analysis of the Epstein-Barr virus recruited regulatory T cells in nasopharyngeal carcinoma of immune escape]. Bi P; Wang J; Lu J; Liu X; Wang F; Luo YF; Peng SD; Li XP Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Sep; 52(9):692-697. PubMed ID: 28910895 [No Abstract] [Full Text] [Related]
19. LncRNA BC200 promotes the development of EBV-associated nasopharyngeal carcinoma by competitively binding to miR-6834-5p to upregulate TYMS expression. Zhang S; Liu N; Cao P; Qin Q; Li J; Yang L; Xin Y; Jiang M; Zhang S; Yang J; Lu J Int J Biol Macromol; 2024 Oct; 278(Pt 4):134837. PubMed ID: 39179085 [TBL] [Abstract][Full Text] [Related]
20. The effect of EBV on WIF1, NLK, and APC gene methylation and expression in gastric carcinoma and nasopharyngeal cancer. Zhao Z; Liu W; Liu J; Wang J; Luo B J Med Virol; 2017 Oct; 89(10):1844-1851. PubMed ID: 28543390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]